Skip to content

THERAGENICS CORP

CIK 0000795551

Revenue (TTM)
$84.43M
+0.7% YoY Q2 Aug 2013
Net Income (TTM)
$1.48M
−146.8% YoY Q2 Aug 2013
EPS Diluted (TTM)
$0.04
−150.0% YoY Q2 Aug 2013
Gross Margin
35.8%
Q2 Aug 2013
Operating Margin
3.1%
Q2 Aug 2013
Net Margin
1.8%
Q2 Aug 2013
Free Cash Flow (TTM)
$3.56M
Q2 Aug 2013
Cash
$16.85M
Q2 Aug 2013
Total Debt
$44M
Q2 Aug 2013
Shares Outstanding
31.22M sh
Q2 Aug 2013

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings